• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ETHICON INC. DERMABOND PRINEO 22CM MSH 3.8ML ADHESIVE; SURGICAL SEALANT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ETHICON INC. DERMABOND PRINEO 22CM MSH 3.8ML ADHESIVE; SURGICAL SEALANT Back to Search Results
Catalog Number CLR222
Medical Device Problem Code Adverse Event Without Identified Device or Use Problem (2993)
Health Effect - Clinical Codes Erythema (1840); Hypersensitivity/Allergic reaction (1907)
Date of Event 01/01/2026
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
Product complaint # (b)(4).This report is being submitted pursuant to the provisions of 21 cfr, part 803.This report may be based on information which has not been investigated or verified prior to the required reporting date.This report does not reflect a conclusion by ethicon inc, or its employees that the report constitutes an admission that the product, ethicon inc, or its employees caused or contributed to the potential event described in this report.If information is obtained that was not available for the initial report, a follow-up report will be filed as appropriate.D4: udi: as the lot number for the device involved in the event was not provided, the full udi is currently not available.Attempts have been made to retrieve the device.To date the device has not been returned.If the device or further details are received at a later date a supplemental medwatch will be sent.Additional information was requested, and the following was obtained: what is the procedure name? humerus fixation.What is the procedure date: (b)(6) 2025.What date did the reaction occur on? 7- 10 days after surgery.What does the reaction look like and how large of an area does the reaction cover? full body.Started at wound site, spread around whole body from the wound site and all around patients body, back, legs, genitals.Looked like patchy redness under surface of skin.Do you have any pictures of the reaction? no consent to send but surgeon showed me photos in person.Was there any medical or surgical intervention performed (product removed; re-operation; re-closure; prescription medication)? if so, please specify.Antibiotics, antihistamines, removed dressing.If medication was required, please clarify if it was prescription strength.Antibiotics yes.What is the most current patient status? reaction cleared up following antihistamines and antibiotics.Was prineo/dermabond or skin adhesive used on the patient in a previous surgery or wound closure? unknown.Please provide the source or title of external person providing answers to follow-up: mr (b)(6).Is the product available to be returned for evaluation? no.Unknown which batch/ lot number.Attempts are being made to obtain the following information.To date no response has been provided.If further details are received at a later date a supplemental medwatch will be sent: please describe how the adhesive was applied.How was the wound cleaned and dried prior to prineo/ dermabond application? what prep was used prior to, during or after adhesive use? was a dressing placed over the incision? if so, what type of cover dressing was used? is the patient hypersensitive or do they have allergies to cyanoacrylate or formaldehyde? is the patient hypersensitive to pressure sensitive adhesives? was patient screening done prior the procedure, e.G.Check patient is not allergic to cyanoacrylate, formaldehyde, bac, pressure-sensitive adhesive? patient demographics: initials / id, gender, age or date of birth, bmi? patient pre-existing medical conditions (ie.Allergies, history of reactions)? has the patient used or been exposed to similar glues/agents for repair, crafts, cosmetic use (lashes, nails)? was prineo/dermabond or skin adhesive used on the patient in a previous surgery or wound closure? what is the physician¿s opinion as to the etiology of or contributing factors to this event?.
 
Event or Problem Description
It was reported that a patient underwent a humerus fixation procedure on (b)(6) 2025 and topical skin adhesive was used.7-10 days after surgery, the patient developed a severe allergic reaction to the topical skin adhesive.The reaction was full body.Started at wound site, spread around whole body from the wound site and all around patients body, back, legs, genitals.Looked like patchy redness under surface of skin.Patient was given antibiotics, antihistamines and removed dressing.The reaction cleared up following antihistamines and antibiotics.Additional information was requested.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
DERMABOND PRINEO 22CM MSH 3.8ML ADHESIVE
Common Device Name
SURGICAL SEALANT
Manufacturer (Section D)
ETHICON INC.
1000 route 202
raritan NJ 08869
Manufacturer (Section G)
ETHICON INC.-SAN LORENZO PR
road 183, km 8.3
san lorenzo PR 00754
*   00754
Manufacturer Contact
orla o'mahony
1000 route 202
raritan, NJ 08869
3035526892
MDR Report Key24161612
Report Number2210968-2026-00920
Device Sequence Number15850568
Product Code OMD
UDI-Device Identifier10705031237339
UDI-Public10705031237339
Combination Product (Y/N)N
Initial Reporter CountryUK
PMA/510(K) Number
K133864
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source Foreign,Health Professional,User Facility,Company Representative
Initial Reporter Occupation Other
Type of Report Initial
Report Date (Section B) 01/23/2026
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Catalogue NumberCLR222
Was Device Available for Evaluation? No
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 01/05/2026
Initial Report FDA Received Date01/23/2026
Was Device Evaluated by Manufacturer? (Y/N) No
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Required Intervention;
Patient SexUnknown
-
-